中国药学杂志
    
           首页  |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告服务  |  会议信息  |  联系我们  | 
�й�ҩѧ��־ 2013, Vol. 48 Issue (14) :1217-1221    DOI: 10.11669/cpj.2013.14.022
ҩ�¹��� ����Ŀ¼ | ����Ŀ¼ | ������� | �߼����� << [an error occurred while processing this directive] | [an error occurred while processing this directive] >>
�й���ҩ��ҵ�������г���Ӧ����Ȩ����ҩ�����IJ����о�
������1����ѩ��2*
1.���пƼ���ѧ֪ʶ��Ȩս���о�Ժ, �人 430074;
2.ͬ�ô�ѧ֪ʶ��ȨѧԺ,�Ϻ� 200092
LIU Li-chun1, ZHU Xue-zhong2*
1. Institute of Intellectual Property Strategy, Huazhong University of Science & Technology, Wuhan 430074, China

Download: PDF (1236KB)   HTML (1KB)   Export: BibTeX or EndNote (RIS)      Supporting Info
ժҪ Ŀ�� ͨ����������Ȩ����ҩս��ԭ���ص��Լ�Ӱ������о�,Ϊ�й�ѧ��̽����Ȩ����ҩս���Լ��й���ҩ��ҵ�������г�������Ȩ����ҩ����ʱ�ṩ��������� ͨ���������������߽���,�ܽ�Ʒ��ҩ�����������г���ʹ����Ȩ����ҩ���Ե��ص㡣�������� �ɹ�����Ȩ����ҩս���ܹ�ʹƷ��ҩ���̵IJ�Ʒ��ר�����ں����ܺ�ά�ֽϴ���г��ݶ�й���ҩ��ҵ��Ҫ�������������������г�ѡ��ͬ����Ȩ����ҩ���ԡ�
Service
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
Email Alert
RSS
�����������
������
��ѩ��*
�ؼ����� ��Ȩ����ҩ   ��������ҩ   Ʒ��ҩ   ר��   ս��     
Abstract�� ObjectiveTo study the principle, feature and impact of the authorized generics strategy in American drug market, thus to provide some references for Chinese scholars who research the authorized generics strategy and for China pharmaceutical companies that would face competition in American pharmaceutical market. Methods By case study and policies analysis, the ways how the brand-name companies used the authorized generics in American drug market were summarized. Results AND Conclusion Successful authorized generics strategy can maintain a large market share of the brand-name companies products. In American drug market, there are some particularities about the authorize generics strategy due to the features of American drug policies and regulations. China pharmaceutical companies should implement different authorized generics strategy according to their own conditions in American drug market at present.
Keywords�� authorized generics,   independent generics,   brand-name drug,   patent strategy     
�ո�����: 2011-12-28;
��������:

������Ȼ��ѧ����������Ŀ(71003037);��������������ѧ�о�һ����Ŀ(11YJA630224)

ͨѶ���� ��ѩ��,��,����,��ʿ����ʦ �о�����֪ʶ��Ȩ���� Tel(027)87556444 E-mailxzzhu@hotmail.com     Email: xzzhu@hotmail.com
���߼��: ������,��,��ʿ�о��� �о�����ҩƷ֪ʶ��Ȩ
���ñ���:   
������, ��ѩ��* .�й���ҩ��ҵ�������г���Ӧ����Ȩ����ҩ�����IJ����о�[J]  �й�ҩѧ��־, 2013,V48(14): 1217-1221
LIU Li-Chun-, ZHU Xue-Zhong-* .Research on Strategy of China Pharmaceutical Companies Coping with Competition of Authorized Generics in American Drug Market[J]  Chinese Pharmaceutical Journal, 2013,V48(14): 1217-1221
��
[1] CHEN X Q, JIN Y Y, TANG G . New Pharmacological. Seventeenth Edition (�±�ҩ��ѧ, ��ʮ�߰�) . Beijing: People’ Medical Publishing House, 2011: 427. New Pharmacological. Seventeenth Edition (??��???��?��????-|, ????????????) . Beijing: People target="_blank">
[2] HONG B. Ambroxol Hydrochloride Injection caused eight cases of adverse reactions. Her Med (ҽҩ����), 2010, 29(9): 1242-1243.
[3] LI L J. Ambroxol hydrochloride Injection caused two cases of adverse reactions . Chin Pharm (�й�ҩҵ), 2009, 18(18): 78.
[4] XIE J Y. Ambroxol Hydrochloride Injection caused one case of adverse reaction . Chin J Hosp Pharm (�й�ҽԺҩѧ��־), 2009, 29(1): 65.
[5] LIU Y P, YANG X Y, YIN C Y. Ambroxol Hydrochloride for Injection caused one case of adverse reaction . Northwest Pharm J (����ҩѧ��־), 2008, 23(6): 386.
[6] PING P. Ambroxol Hydrochloride injection caused one case of speed hypersensitivity . J Med Theor Prac (ҽѧ������ʵ��), 2010, 23(9): 1121.
[7] WANG T, GUAN D W, ZHAO R, et al. Intravenous infusion of Ambroxol Hydrochloride induced one case of annphylactic shock and death . Chin J Fore Med (�й���ҽѧ��־), 2010, 25(3): 201-202.
Copyright 2010 by �й�ҩѧ��־